1-stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine

Metabolite details

Identifier

AGTPCXBHIGMTEU-NREGDSCDSA-N

InChI Key

AGTPCXBHIGMTEU-NREGDSCDSA-N

IUPAC name

O-{hydroxy[(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(octadecanoyloxy)propoxy]phosphoryl}-L-serine

Preferred name

1-stearoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine

INN name

—

Synonym

Phosphatidylserine(18:0/18:2w6)

ChEBI

CHEBI:84513

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_vs_Palmitate
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• BSA_Control_vs_AA